Erişkinlerde Erken Dönemde veya Selektif Olarak Solunum Yetmezliğine Neden Olan Nöromusküler Hastalıklar

Filiz Koç

TR EN

Erişkinlerde Erken Dönemde veya Selektif Olarak Solunum Yetmezliğine Neden Olan Nöromusküler Hastalıklar

Öz

Özet bulunmuyor

Anahtar Kelimeler

nöromüsküler hastalıklar, nöroloji

Kaynakça

De Die-Smulders CEM, Höweler CJ, Thijs C, et al. Age and causes of death in adult onset myotonic dystrophy. Brain 1998;121:1557-1563.
Koç F, Sarıca Y. Mitokondriyal Hastalıklar. Çukurova Üniversitesi Tıp Fakültesi Arşiv Dergisi, 2003; 12:32-79.
DiMauro S, Bonilla E, Zeviani M, et al. Mitochondrial myopathies. Ann Neurol 1985; 17: 521- 38.
Cros D, Palliyath S, DiMauro S, et al. Respiratory Failure Revealing Mitochondrial Myopathy in Adults. Chest 1992; 101:824-28.
D Cros, S Palliyath, S DiMauro, et al. Respiratory failure revealing mitochondrial myopathy in adults. Chest. 1992;101; 824-828.
Carroll JE, Zwillich C, Weil JV, et al. Depressed ventilatory response in oculocraniosomatic neuromuscular disease. Neurology 1976; 26: 140-46.
Pavlakis SG, Phillips PC, DiMauro 5, et al.. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: adistinctive clinical syndrome. Ann Neurol 1984; 16: 481- 88.
Zeviani M, Bonilla E, DeVivo DC, et al.. Mitochondrial diseases. Neurol Clinics 1989; 7:123- 56.
Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 1951;14:216-221.
Masó E, Ferrer I, Herraiz J, et al. syndrome in an adult. J Neurol. 1984; 231:253-7.

Cummiskey J, Guilleminault C, Davis R, et al. Automatic respiratory failure: sleep studies and Leigh's disease (case report). Neurology. 1987; 37:1876-8.
Arii J, Tanabe Y. Leigh syndrome: Serial MR imaging and clinical follow-up. Am J Neuroradiol 2000; 21:1502-9
Rahman S, Blok RB, Dahl HH, et al.. Leigh syndrome: Clinical features and biochemical and DNA abnormalities. Ann Neurol 1996; 39: 343-51.
Behrman RE.: Nelson Textbook of Pediatrics. 16th ed. WB Saunders Co; 2000: 411-13.
Ausems MG, Lochman P, van Diggelen OP, et al. A diagnostic protocol for adult-onset glycogen storage disease type II. Neurology 1999;52: 851-53.
Ausems MG, Verbiest J, Hermans MP, et al. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet 1999;7: 713-16.
Melvin JJ. Pompe's disease. Arch Neurol 2000; 57: 134-5.
Chen YT, Amalfitano A. Towards a molecular therapy for glycogen storage disease type II (Pompe disease). Mol Med Today 2000;6:245-251.
Koç F, Zorludemir S, Sarıca Y. Adult başlangıçlı asit maltaz eksikliği. Gülhane Tıp Dergisi. 2003; 45: 277-280.
Barnes D, Hughes RA, Spencer GT. Adult onset acid maltase deficiency with prominent bulbar involvement and ptosis. J R Soc Med. 1993; 86: 50.
Margolis ML, Howlett P, Goldberg R, et al. Obstructive sleep apnea syndrome in acid maltase deficiency. Chest 1994; 105: 947-9. Conen PE, Murphy EG, Donohue WL. Light and electron microscopic studies of “myogranules” in a child with hypotonia and muscle weakness. Can Med Assoc J. 1963; 89: 983-6.
Shy GM, Engel WK, Somers JE, et al. Nemaline myopathy: a new congenital myopathy.
Brain. 1963; 86: 793-810.
Sanoudou D, Beggs AH. Clinical and genetic heterogeneity in nemaline myopathy a disease of skeletal muscle thin filaments. Trends Mol Med. 2001; 7: 362-68.
Lomen-Hoerth C, Simmons ML, Dearmond SJ, et al. Adult-onset nemaline myopathy: another cause of dropped head. Muscle & Nerve. 1999; 22: 1146- 50.
Agrawal PB, Strickland CD, Midgett C, et al. Heterogeneity of nemaline myopathy cases with skeletal muscle alpha-actin gene mutations. Ann Neurol. 2004; 56: 86-96.
Keller CE, Hays AP, Rowland LP Moghadaszadeh B, et al.-Onset Nemaline Myopathy and Monoclonal Gammopathy. Arch Neurol. 2006; 63: 132-134.
Chinnery PF, Johnson MA, Walls TJ, et al. A novel autosomal dominant distal myopathy with early respiratory failure: clinico-pathologic characteristics and exclusion of linkage to candidate genetic loci. Ann Neurol. 2001;49: 443-52.
Birchall D, von der Hagen M, Bates D, et al. Subclinical semitendinosus and obturator externus involvement defines an autosomal dominant myopathy with early respiratory failure. Neuromuscular Disord. 2005;15: 595-600.
Edstrom L, Thornell LE, Albo J, et al. Myopathy with respiratory failure and typical myofibrillar lesions. Journal of Neurol. Sci. 1990; 96: 211-28.
Nicolao P, Xiang F, Gunnarsson LG, et al. Autosomal dominant myopathy with proximal weakness and early respiratory muscle involvement maps to chromosome 2q. Am. J. Hum. Genet. 1999; 64: 788-792.
Xiang F, Nicolao P, Chapon F,et al. A second locus for autosomal dominant myopathy with proximal muscle weakness and early respiratory muscle involvement: a likely chromosomal locus on 2q21. Neuromuscular Disord. 1999; 9: 308- 12.
MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet. 1977; 2: 615.
Lacomis D, Zochodne DW, Bird SJ. Critical illness myopathy. Muscle & Nerve. 2000 ;23: 1785-8.
Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care. 2005;11: 126-32.
Bednarik J, Lukas Z, Vondracek P. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med 2003; 29: 1505- 1514.
Trojaborg W, Weimer LH, Hays AP. Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy--a reappraisal. Clin Neurophysiol.2001;112: 1586-93.
Young GB, Hammond RR. A stronger approach to weakness in the intensive care unit. Critical care 2004; 8: 416-18.
Stibler H, Edstrom L, Ahlbeck K, et al. Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med. 2003; 29:1515-27.
Latronico N, Shehu I, Seghelini E. Neuromuscular sequelae of critical illness. Curr Opin Crit Care 2005; 11: 381-90.
Schwartz M. The lung in polymyositis. Clin Chest Med 1998;19: 701-12.
Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med. 2001;164: 1182-5.
Rossman MD, Thompson B, Frederick M, et al. ACCESS Group: HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am. J Hum. Genet. 2003;73: 720- 35.
Takuma H, Murayama S, Watanabe M, eet al. A severe case of subacute sarcoid myositis. J Neurol Sci. 2000;15;175:140-4.
Yee AM, Pochapin MB. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med. 2001;135: 27-31.
Sanders DB, Howard JF. Disorders of neuromuscular transmission. In:Bradley WG, Daroff RB, Fenichel GM, Mariden CD eds, Neurology in clinical practice. Buttreworth-Heinmann, 2000: 2167-181.
http://www.millipediatri.org.tr/bildiriler/PP-126.htm
Deymeer F. Nöromüsküler kavşlak hastalıkları. In: Oğul O, ed. Nöroloji. Bursa, Nobel tıp
kitabevi 2000: 373-379.
Ursavaş A, Karlı N, Karadağ M, ve ark.. Myastenik kriz nedeniyle akut solunum yetmezliği
gelişen bir hastada noninvaziv mekanik ventilasyon. Solunum 2004; 6:118-124. Bedlack RS, Sanders DB. How to handle myasthenic crisis. Myastenik krizde noninvazif mekanik ventilasyon. Postgrad Med 2000;107:211-222.
Thomas CE, Mayer SA, Gungor Y, ve ark. Myasthenic crisis: clinical features, mortality,
complications and risk factors for prolonged intubation. Neurology 1997;48: 1253-60.
Ferguson IT, Murphy RP, Lascelles RG. Ventilatory failure in myasthenia gravis. J Neurol
Neurosurg Psychiat 1982;45: 217-222.
Provencio JJ, Bleck TP, Connors AF. Critical care neurology. Am J Respir Crit Care Med 2001;164:341-45.
Nicolle MW, Stewart DJ, Remtulla H, et al.-Eaton myasthenic syndrome presenting with severe respiratory failure. Muscle & Nerve. 1996;19:1328-33.
Barr CW, Claussen G, Thomas D,et al. Primary respiratory failure as the presenting symptom in Lambert-Eaton myasthenic syndrome. Muscle & Nerve. 1993;16:712-5.
Tseng A, Claussen G, Shin J. Respiratory Failure in Lambert-Eaton Myasthenic Syndrome Precipitated by Calcium-Channel Blockers: Report of a Case and Literature Review. Journal of Clinical Neuromuscular Disease 2002;4:60-63.
Gordon AS, John W. Acute ventilatory failure in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine. Neurology 1996;46:1143-1145.
Van der Meche FG, Visser LH, Jacobs BC, et al. Guillain-Barre syndrome :multi- factorial mechanisms versus defined subgroups. J Infect Dis 1997;176 Suppl 2: 99-102.
Ho T, Griffin J. Guillain-Barre syndrome. Curr Opin Neurol 1999;12: 389-94.
Hahn AF. Guillain-Barre syndrome. Lancet 1998; 352: 635-41.
Saida K. The immunopathology of Guillain-Barre syndrome. Curr Opin Neurol 1996; 9: 329- 333.
Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain Barré syndrome. Ann Neurol 1990; 27: 21-24.
Hund EF, Borel CO, Cornblath DR, et al. Intensive management and treatment of severe Guillain-Barre syndrome. Crit Care Med 1993;21: 433-46.
Maher J, Rutledge F, Remtulla H, et al. Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 1995;21:737-43.
Austin JH. Recurrent polyneuropathies and their corticosteroid treatment. Brain 1958;81:157- 192.
Dyck PJ, Lais AJ, Ohta M, et al. Chronic inflammatory polyradiculopathy. Mayo Clin Proc 1975; 50:621-37.
Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force: Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991; 41: 617-618.
Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989;46: 878-84.
Cornblatt DR, Griffin DE, Welch D, et al. Quantitative analysis of endoneurial T-cells in human sural nerve biopsies. J Neuroimmunol 1990;26:113-118.
Dyck PJ, Lais AJ, Ohta M, et al. Chronic inflammatory polyradiculopathy. Mayo Clin Proc 1975;50: 621-37.
Costa J, de Carvalho M. Chronic inflammatory demyelinating polyneuropathy, phrenic nerve and respiratory symptoms. Eur J Neurol. 2005;12:64-6.
Henderson RD, Sandroni P, Wijdicks EF. Chronic inflammatory demyelinating polyneuropathy and respiratory failure. J Neurol. 2005;252:1235-7.
Kimber TE, Orrell RW, King RH, et al. Pathological findings in a patient with ventilatory failure and chronic inflammatory demyelinating polyneuropathy. Journal of the Peripheral Nervous System. 2003; 8:13-16.
Sasaki M, Ohara S, Oide T, et al. An autopsy case of chronic inflammatory demyelinating polyradiculoneuropathy with respiratory failure. Muscle & Nerve. 2004; 30: 382-7.
Cocito D, Ciaramitaro P, Rota E, et al. Subclinical electrophysiological alterations of phrenic nerve in chronic inflammatory demyelinating polyneuropathy. J Neurol. 2005; 252: 916-20.
Ouvrier RA, Nicholson GA. Advances in the genetics of hereditary hypertrofic neuropathy in chilhood. Brain Dev 1995; 17 suppl: 31-38.
Lupski JR, Chance PF, Garcia CA. İnherited primary peripheral neuropathies. JAMA 1993; 270: 2326-30.
Davide Pareyson, MD. Charcot-Marie-Tooth Disease and Releated Neuropathies: Molecular basis for distinctions and diagnosis. Muscle & Nerve 1999;22: 1498-1509.
Darquennes K, De Jonghe P, Daems D, et al. Intermittent positive airway pressure by nasal mask as a treatment for respiratory insufficiency in a patient with Charcot-Marie-Tooth disease. Acta Clin Belg. 2006;61:176-81.
Teramoto S, Ishii T, Matsuse T. Central sleep apnoeas in patients with Charcot-Marie-Tooth disease. Lancet. 2001 Jan 27;357:267-72.
Dematteis M, Pépin JL, Jeanmart M, et al. Charcot-Marie-Tooth disease and sleep apnoea syndrome: a family study. Lancet. 2001;358: 70-1.
Osanai S, Akiba Y, Nakano H, et al. Charcot-Marie-Tooth disease with diaphragmatic weakness. Intern Med. 1992; 31:1267-70.
Chan CK, Mohsenin V, Loke J, et al. Diaphragmatic dysfunction in siblings with hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease). Chest. 1987; 91: 567-70. Liedholm LJ, Eeg-Olofsson O, Ekenberg BE, et al., Acute postasthmatic amyotrophy (Hopkins' syndrome). Muscle Nerve. 1994;17: 769-72.
Kyllerman MG, et al. PCR diagnosis of primary herpesvirus type I in poliomyelitis-like paralysis and respiratory tract disease. Pediatr Neurol. 1993; 9:227-9.
Acharya AB, Lakhani PK. Hopkins syndrome associated with Mycoplasma infection. Pediatr Neurol. 1997; 16: 54-5. Arita J, Nakae Y, Matsushima H, Maekawa K. Hopkins syndrome: T2-weighted high intensity of anterior horn on spinal MR imaging. Pediatr Neurol. 1995;13: 263-5.
www.asicalismagrubu.org/
Sabatelli M, Quaranta L, Madia F, et al. Peripheral neuropathy with hypomyelinating features
in adult-onset Krabbe's disease. Neuromuscular Disord. 2002; 12: 386-91.
Polkey MI, Lyall RA, Green M, et al. Expiratory muscle function in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 1998;158: 734–41.
Chaudri MB, Liu C, Hubbard R, et al. Relationship between supramaximal flow during cough and mortality in motor neurone disease Eur Respir J. 2002; 19: 434-8.
Hillel AD, Miller R. Bulbar amyotrophic lateral sclerosis: patterns of progression and clinical management. Head & Neck 1989;11:51–59.
Murty GE, Lancaster P, Kelly PJ. Cough intensity in patients with a vocal cord palsy. Clin Otolaryng 1991;16: 248–251.
Jackson CE, Rosenfeld J, Moore DH, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. Journal of the Neurological Sciences 2001; 191; 75-78.
Lechtzin N, Rothstein J, Clawson L, et al. Amyotrophic lateral sclerosis: Evaluation and treatment of respiratory impairment. ALS and Other Motor Neuron Disorders 2002; 3:5-13.
Varrato DO, Siderowf A, Damiano P, et al. Postural change of forced vital capacity predicts some respiratory symptoms in ALS. Neurology 2001; 57: 357-359.
www.cignamedicare.com/dmerc/dlog/dlog2004/winter_2004.
Kleopa KA, Sherman M, Neal B, et al.. Bipap improves survival and rate of pulmonary function decline in patients with ALS. Journal of the Neurological Sciences 1999; 164: 82-88.
Bach JR. Amyotrophic lateral sclerosis: Prolongation of life by noninvasive respiratory aids. Chest 2002; 722: 92-98.
Sivak ED, Shefner JM, Mitsumoto H, et al. The use of non- invasive positive pressure ventilation (NIPPV) in ALS patients. A need for improved determination of intervention timing. ALS and Other Motor Neuron Disorders 2001; 2: 139- 145.
Agre JC, Rodriquez AA, Tafel JA. Late effects of polio: critical review of the literature on neuromuscular function. Arch Phys Med Rehabil 1991;72: 923-31.
On Yağız A. Geç Dönem Poliomiyelitte Sınıflama, Klinik Özellikler ve Yaşam Kalitesi. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi 2001;47. (www.ftrdergisi. com)
Dalaks MC. How to design a therapeutic study in patients with post-polio syndrome. Methodological concerns and status of present therapies. Ann NY Acad Sci 1995; 753: 314- 20.
Halstead LS, Rossi CD. New problems in old polio patients: result of survey of 539 polio survivors. Orthopedics 1985; 8: 845-50.
McComas AJ, Quartly C, Griggs C. Early and late losses of motor units after poliomyelitis. Brain 1997;120:1415- 21.
Dalakas MC. Pathogenetic mechanisms of post-polio syndrome: morphological, electrophysiological, virological and immunological correlations. (Review). Ann NY Acad Sci 1995; 753:167-185.
Eirnasson G, Grimby G, Stalberg E. Electromyographic and morphological functional compensation in late poliomyelitis. Muscle Nerve 1990;13:165-171.
Cosgrove JL, Alexander MA, Kitts EL, et al. Late effects of poliomyelitis. Arch Phys Med Rehabil 1987; 68:47.
Willen C, Grimby G. Pain, Physical activity and disability in individuals with late effects of polio. Arch Phys Med Rehabil 1998;79: 915-919.

Ayrıntılar

Birincil Dil

Türkçe

Konular

-

Bölüm

-

Yazarlar

Filiz Koç Bu kişi benim

Yayımlanma Tarihi

1 Aralık 2007

Gönderilme Tarihi

30 Ekim 2014

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2007 Cilt: 16 Sayı: 4

IZ

https://izlik.org/JA45DZ35TZ

APA

Koç, F. (2007). Erişkinlerde Erken Dönemde veya Selektif Olarak Solunum Yetmezliğine Neden Olan Nöromusküler Hastalıklar. Arşiv Kaynak Tarama Dergisi, 16(4), 245-282. https://izlik.org/JA45DZ35TZ

AMA

1.Koç F. Erişkinlerde Erken Dönemde veya Selektif Olarak Solunum Yetmezliğine Neden Olan Nöromusküler Hastalıklar. aktd. 2007;16(4):245-282. https://izlik.org/JA45DZ35TZ

Chicago

Koç, Filiz. 2007. “Erişkinlerde Erken Dönemde veya Selektif Olarak Solunum Yetmezliğine Neden Olan Nöromusküler Hastalıklar”. Arşiv Kaynak Tarama Dergisi 16 (4): 245-82. https://izlik.org/JA45DZ35TZ.

EndNote

Koç F (01 Aralık 2007) Erişkinlerde Erken Dönemde veya Selektif Olarak Solunum Yetmezliğine Neden Olan Nöromusküler Hastalıklar. Arşiv Kaynak Tarama Dergisi 16 4 245–282.

IEEE

[1]F. Koç, “Erişkinlerde Erken Dönemde veya Selektif Olarak Solunum Yetmezliğine Neden Olan Nöromusküler Hastalıklar”, aktd, c. 16, sy 4, ss. 245–282, Ara. 2007, [çevrimiçi]. Erişim adresi: https://izlik.org/JA45DZ35TZ

ISNAD

Koç, Filiz. “Erişkinlerde Erken Dönemde veya Selektif Olarak Solunum Yetmezliğine Neden Olan Nöromusküler Hastalıklar”. Arşiv Kaynak Tarama Dergisi 16/4 (01 Aralık 2007): 245-282. https://izlik.org/JA45DZ35TZ.

JAMA

1.Koç F. Erişkinlerde Erken Dönemde veya Selektif Olarak Solunum Yetmezliğine Neden Olan Nöromusküler Hastalıklar. aktd. 2007;16:245–282.

MLA

Koç, Filiz. “Erişkinlerde Erken Dönemde veya Selektif Olarak Solunum Yetmezliğine Neden Olan Nöromusküler Hastalıklar”. Arşiv Kaynak Tarama Dergisi, c. 16, sy 4, Aralık 2007, ss. 245-82, https://izlik.org/JA45DZ35TZ.

Vancouver

1.Filiz Koç. Erişkinlerde Erken Dönemde veya Selektif Olarak Solunum Yetmezliğine Neden Olan Nöromusküler Hastalıklar. aktd [Internet]. 01 Aralık 2007;16(4):245-82. Erişim adresi: https://izlik.org/JA45DZ35TZ

Erişkinlerde Erken Dönemde veya Selektif Olarak Solunum Yetmezliğine Neden Olan Nöromusküler Hastalıklar

Erişkinlerde Erken Dönemde veya Selektif Olarak Solunum Yetmezliğine Neden Olan Nöromusküler Hastalıklar

Öz

Anahtar Kelimeler

Adult Neuromuscular Diseases Selectively Causing Respiratory Insufficiency

Öz

Anahtar Kelimeler

Kaynakça

Ayrıntılar

Birincil Dil

Konular

Bölüm

Yazarlar

Yayımlanma Tarihi

Gönderilme Tarihi

Kabul Tarihi

Yayımlandığı Sayı

IZ

Kaynak Göster